ACOR - Acorda Therapeutics Inc. (ACOR) CEO Ron Cohen on Q2 2020 Results - Earnings Call Transcript
Acorda Therapeutics, Inc. (ACOR)
Q2 2020 Results Earnings Conference Call
August 04, 2020, 04:30 PM ET
Company Participants
Tierney Saccavino - EVP, Corporate Communications
Ron Cohen - Founder, CEO, President
Conference Call Participants
Michael Yee - Jefferies
Kenneth Shields - Wedbush Securities
Ram Selvaraju - H.C. Wainwright
Kenneth Atkins - Cowen and Company
Presentation
Operator
Welcome to Acorda Therapeutics Second Quarter 2020 Financial and Business Update. At this time all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being taped at the